1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow 3+7: new trials by email Literature Review of 3+7 trials Research Report on 3+7
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia CACAG+VEN, 3+7 - Acute Monocytic Leukemia | Phase 2 | Recruiting | Chinese PLA General Hospital | 204 | 2025-09-01 | 2026-04-06 |
| Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms Induction Chemotherapy, Consolidation Chemotherapy, Autologous Stem Cell Transplantation - Acute Myeloid Leukemia, Myeloproliferative Neoplasms | Phase 2 | Completed | Hospital Israelita Albert Einstein | 455 | 2012-10-01 | 2016-11-08 |
Anemia, Refractory, with Excess of Blasts (1) · Leukemia (1) · Leukemia, Monocytic, Acute (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1) · Polycythemia Vera (1) · Primary Myelofibrosis (1) · Thrombocythemia, Essential (1)
Chinese PLA General Hospital (1) · Hospital Israelita Albert Einstein (1)
Brazil (1) · China (1)
Fabio P Santos, MD (1) · Liping Dou, Doctor (1) · Nelson Hamerschlak, MD, PhD (1)